Search Results

There are 7772 results for: content related to: Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?

  1. You have free access to this content
    HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 127–132, Jiannis Vlachogiannakos and George V. Papatheodoridis

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12404

  2. You have free access to this content
    HBV: Do I treat my immunotolerant patients?

    Liver International

    Volume 36, Issue S1, January 2016, Pages: 93–99, Jiannis Vlachogiannakos and George V. Papatheodoridis

    Version of Record online : 4 JAN 2016, DOI: 10.1111/liv.12996

  3. Contrast-Enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis

    Liver International

    Volume 33, Issue 5, May 2013, Pages: 739–755, Mireen Friedrich-Rust, Tom Klopffleisch, Julia Nierhoff, Eva Herrmann, Johannes Vermehren, Maximilian D. Schneider, Stefan Zeuzem and Joerg Bojunga

    Version of Record online : 22 FEB 2013, DOI: 10.1111/liv.12115

  4. The interferon receptor-1 promoter polymorphisms affect the outcome of Caucasians with HBeAg-negative chronic HBV infection

    Liver International

    Volume 35, Issue 12, December 2015, Pages: 2506–2513, Timokratis Karamitros, George Papatheodoridis, Eleni Dimopoulou, Maria-Vasiliki Papageorgiou, Dimitrios Paraskevis, Gkikas Magiorkinis, Vana Sypsa and Angelos Hatzakis

    Version of Record online : 17 MAY 2015, DOI: 10.1111/liv.12859

  5. You have free access to this content
    Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review

    Liver International

    Volume 34, Issue 10, November 2014, Pages: 1452–1463, George V. Papatheodoridis, Emmanuel Tsochatzis, Svenja Hardtke and Heiner Wedemeyer

    Version of Record online : 16 MAY 2014, DOI: 10.1111/liv.12565

  6. You have free access to this content
    Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature

    Liver International

    Volume 33, Issue 10, November 2013, Pages: 1457–1469, Kirsten E. Pijls, Daisy M. A. E. Jonkers, Elhaseen E. Elamin, Ad A. M. Masclee and Ger H. Koek

    Version of Record online : 23 JUL 2013, DOI: 10.1111/liv.12271

  7. Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options

    Journal of Viral Hepatitis

    Volume 11, Issue 4, July 2004, Pages: 287–296, G. V. Papatheodoridis and E. Cholongitas

    Version of Record online : 29 JUN 2004, DOI: 10.1111/j.1365-2893.2004.00522.x

  8. You have free access to this content
    Liver transplantation: a systematic review of long-term quality of life

    Liver International

    Volume 34, Issue 9, October 2014, Pages: 1298–1313, Linda S. Yang, Leonard L. Shan, Akshat Saxena and David L. Morris

    Version of Record online : 23 APR 2014, DOI: 10.1111/liv.12553

  9. Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion

    The Prostate

    Volume 72, Issue 16, 1 December 2012, Pages: 1719–1735, Lukasz Hudak, Patrick Tezeeh, Steffen Wedel, Jasmina Makarević, Eva Juengel, Igor Tsaur, Georg Bartsch, Christoph Wiesner, Axel Haferkamp and Roman A. Blaheta

    Version of Record online : 2 APR 2012, DOI: 10.1002/pros.22525

  10. You have free access to this content
    Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity

    Liver International

    Volume 34, Issue 8, September 2014, Pages: 1133–1152, Gianluigi Mazzoccoli, Manlio Vinciguerra, Jude Oben, Roberto Tarquini and Salvatore De Cosmo

    Version of Record online : 9 APR 2014, DOI: 10.1111/liv.12534

  11. You have free access to this content
    New therapeutic perspectives in HBV: when to stop NAs

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 146–153, Cristina Pérez-Cameo, Mònica Pons and Rafael Esteban

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12398

  12. You have free access to this content
    Liver tissue engineering and cell sources: issues and challenges

    Liver International

    Volume 33, Issue 5, May 2013, Pages: 666–676, Anwar A. Palakkan, David C. Hay, Anil K. PR, Kumary TV and James A. Ross

    Version of Record online : 15 MAR 2013, DOI: 10.1111/liv.12134

  13. Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat

    Liver International

    Volume 34, Issue 4, April 2014, Pages: 521–534, Ying-Ying Yang, Ren-Shyan Liu, Pei-Chang Lee, Yi-Chen Yeh, Yi-Tsau Huang, Wei-Ping Lee, Kuei-Chuan Lee, Yun-Cheng Hsieh, Fa-Yauh Lee, Tat-Wei Tan and Han-Chieh Lin

    Version of Record online : 2 SEP 2013, DOI: 10.1111/liv.12299

  14. Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic review

    Liver International

    Volume 33, Issue 6, July 2013, Pages: 894–903, Victoria A. Sublette, Mark W. Douglas, Kirsten McCaffery, Jacob George and Kathryn Nicholson Perry

    Version of Record online : 14 APR 2013, DOI: 10.1111/liv.12138

  15. You have free access to this content
    Purinergic signalling during sterile liver injury

    Liver International

    Volume 33, Issue 3, March 2013, Pages: 353–361, André G. Oliveira, Pedro E. Marques, Sylvia S. Amaral, Jayane L. D. Quintão, Bruno Cogliati, Maria L. Z. Dagli, Vera Rogiers, Tamara Vanhaecke, Mathieu Vinken and Gustavo B. Menezes

    Version of Record online : 12 FEB 2013, DOI: 10.1111/liv.12109

  16. You have free access to this content
    The role of HBsAg quantification for monitoring natural history and treatment outcome

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 125–132, Michelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah and Patrick Marcellin

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12075

  17. You have free access to this content
    HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 82–90, Michelle Martinot-Peignoux, Tarik Asselah and Patrick Marcellin

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12735

  18. Genetic variations of superoxide dismutase 2 and cytochrome P450 2E1 in non-alcoholic steatohepatitis

    Liver International

    Volume 34, Issue 6, July 2014, Pages: 931–936, Yi-Shin Huang, Chih-Hao Chang, Tai-Ling Lin and Chin-Lin Perng

    Version of Record online : 4 APR 2014, DOI: 10.1111/liv.12533

  19. You have free access to this content
    Hepatic progenitor cells in liver regeneration: current advances and clinical perspectives

    Liver International

    Volume 34, Issue 10, November 2014, Pages: 1464–1472, Aezam Katoonizadeh, Hossein Poustchi and Reza Malekzadeh

    Version of Record online : 13 MAY 2014, DOI: 10.1111/liv.12573

  20. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 660–672, Kalliopi Zachou, Stella Gampeta, Nikolaos K. Gatselis, Katerina Oikonomou, John Goulis, Menelaos N. Manoussakis, Yves Renaudineau, Dimitrios P. Bogdanos and George N. Dalekos

    Version of Record online : 27 AUG 2014, DOI: 10.1111/liv.12658